ID   SLIT2_RAT               Reviewed;         766 AA.
AC   Q9WVC1;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2004, sequence version 3.
DT   24-JUL-2024, entry version 141.
DE   RecName: Full=Slit homolog 2 protein;
DE            Short=Slit-2;
DE   Flags: Precursor; Fragment;
GN   Name=Slit2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10364234; DOI=10.1074/jbc.274.25.17885;
RA   Liang Y., Annan R.S., Carr S.A., Popp S., Mevissen M., Margolis R.K.,
RA   Margolis R.U.;
RT   "Mammalian homologues of the Drosophila slit protein are ligands of the
RT   heparan sulfate proteoglycan glypican-1 in brain.";
RL   J. Biol. Chem. 274:17885-17892(1999).
RN   [2]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=11754167; DOI=10.1002/cne.10068;
RA   Marillat V., Cases O., Nguyen-Ba-Charvet K.T., Tessier-Lavigne M.,
RA   Sotelo C., Chedotal A.;
RT   "Spatiotemporal expression patterns of slit and robo genes in the rat
RT   brain.";
RL   J. Comp. Neurol. 442:130-155(2002).
RN   [3]
RP   INTERACTION WITH GREM1.
RX   PubMed=15528323; DOI=10.4049/jimmunol.173.10.5914;
RA   Chen B., Blair D.G., Plisov S., Vasiliev G., Perantoni A.O., Chen Q.,
RA   Athanasiou M., Wu J.Y., Oppenheim J.J., Yang D.;
RT   "Bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with
RT   Slits and act as negative regulators of monocyte chemotaxis.";
RL   J. Immunol. 173:5914-5917(2004).
CC   -!- FUNCTION: Thought to act as molecular guidance cue in cellular
CC       migration, and function appears to be mediated by interaction with
CC       roundabout homolog receptors. During neural development involved in
CC       axonal navigation at the ventral midline of the neural tube and
CC       projection of axons to different regions. SLIT1 and SLIT2 seem to be
CC       essential for midline guidance in the forebrain by acting as repulsive
CC       signal preventing inappropriate midline crossing by axons projecting
CC       from the olfactory bulb. In spinal cord development may play a role in
CC       guiding commissural axons once they reached the floor plate by
CC       modulating the response to netrin. In vitro, silences the attractive
CC       effect of NTN1 but not its growth-stimulatory effect and silencing
CC       requires the formation of a ROBO1-DCC complex. May be implicated in
CC       spinal cord midline post-crossing axon repulsion. In vitro, only
CC       commissural axons that crossed the midline responded to SLIT2. In the
CC       developing visual system appears to function as repellent for retinal
CC       ganglion axons by providing a repulsion that directs these axons along
CC       their appropriate paths prior to, and after passage through, the optic
CC       chiasm. In vitro, collapses and repels retinal ganglion cell growth
CC       cones. Seems to play a role in branching and arborization of CNS
CC       sensory axons, and in neuronal cell migration. Seems to be involved in
CC       regulating leukocyte migration (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Binds ROBO1 and ROBO2 with high affinity (By
CC       similarity). Interacts with GREM1. {ECO:0000250,
CC       ECO:0000269|PubMed:15528323}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: Detected at 20 dpc, between P0 and P10, and in
CC       adult in anterior olfactory nuclei, in cortex entorhinal region,
CC       hippocampal C3 and dentate gyrus, basal telencephalon septum,
CC       hypothalamus ventromedial and preoptic nuclei and dorsal thalamus
CC       medial habenula. Detected at 20 dpc in cortex cortical plate. Detected
CC       between P0 and P10, and in adult basal telencephalon amygdaloid
CC       complex, and diencephalon pretectum optic tract nuclei.
CC       {ECO:0000269|PubMed:11754167}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD38940.2; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the C-terminal part.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF141386; AAD38940.2; ALT_TERM; mRNA.
DR   AlphaFoldDB; Q9WVC1; -.
DR   SMR; Q9WVC1; -.
DR   IntAct; Q9WVC1; 1.
DR   STRING; 10116.ENSRNOP00000005477; -.
DR   GlyCosmos; Q9WVC1; 4 sites, No reported glycans.
DR   GlyGen; Q9WVC1; 4 sites.
DR   PhosphoSitePlus; Q9WVC1; -.
DR   PaxDb; 10116-ENSRNOP00000005477; -.
DR   AGR; RGD:69310; -.
DR   RGD; 69310; Slit2.
DR   eggNOG; KOG4237; Eukaryota.
DR   InParanoid; Q9WVC1; -.
DR   PhylomeDB; Q9WVC1; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0044297; C:cell body; IDA:RGD.
DR   GO; GO:0042995; C:cell projection; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IEA:InterPro.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0098966; C:perisynaptic extracellular matrix; IDA:SynGO.
DR   GO; GO:0045499; F:chemorepellent activity; ISO:RGD.
DR   GO; GO:0004963; F:follicle-stimulating hormone receptor activity; IEA:InterPro.
DR   GO; GO:0005095; F:GTPase inhibitor activity; ISO:RGD.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; IDA:RGD.
DR   GO; GO:0008201; F:heparin binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043237; F:laminin-1 binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0043394; F:proteoglycan binding; ISO:RGD.
DR   GO; GO:0048495; F:Roundabout binding; ISO:RGD.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISO:RGD.
DR   GO; GO:0061364; P:apoptotic process involved in luteolysis; ISO:RGD.
DR   GO; GO:0048846; P:axon extension involved in axon guidance; ISO:RGD.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; ISO:RGD.
DR   GO; GO:0002042; P:cell migration involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; ISO:RGD.
DR   GO; GO:0071504; P:cellular response to heparin; ISO:RGD.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEP:RGD.
DR   GO; GO:0021836; P:chemorepulsion involved in postnatal olfactory bulb interneuron migration; ISO:RGD.
DR   GO; GO:0021972; P:corticospinal neuron axon guidance through spinal cord; ISO:RGD.
DR   GO; GO:0033563; P:dorsal/ventral axon guidance; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0050929; P:induction of negative chemotaxis; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0060763; P:mammary duct terminal end bud growth; ISO:RGD.
DR   GO; GO:0060603; P:mammary gland duct morphogenesis; ISO:RGD.
DR   GO; GO:0001656; P:metanephros development; ISO:RGD.
DR   GO; GO:0008045; P:motor neuron axon guidance; ISO:RGD.
DR   GO; GO:0050919; P:negative chemotaxis; ISO:RGD.
DR   GO; GO:0030837; P:negative regulation of actin filament polymerization; ISO:RGD.
DR   GO; GO:0030517; P:negative regulation of axon extension; ISO:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0090288; P:negative regulation of cellular response to growth factor stimulus; ISO:RGD.
DR   GO; GO:0070100; P:negative regulation of chemokine-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0010596; P:negative regulation of endothelial cell migration; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0010593; P:negative regulation of lamellipodium assembly; ISO:RGD.
DR   GO; GO:0002689; P:negative regulation of leukocyte chemotaxis; ISO:RGD.
DR   GO; GO:0090027; P:negative regulation of monocyte chemotaxis; IDA:BHF-UCL.
DR   GO; GO:0071676; P:negative regulation of mononuclear cell migration; ISO:RGD.
DR   GO; GO:0090024; P:negative regulation of neutrophil chemotaxis; ISO:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0090260; P:negative regulation of retinal ganglion cell axon guidance; ISO:RGD.
DR   GO; GO:0051058; P:negative regulation of small GTPase mediated signal transduction; ISO:RGD.
DR   GO; GO:0071672; P:negative regulation of smooth muscle cell chemotaxis; ISO:RGD.
DR   GO; GO:0014912; P:negative regulation of smooth muscle cell migration; ISO:RGD.
DR   GO; GO:0043116; P:negative regulation of vascular permeability; ISO:RGD.
DR   GO; GO:1990138; P:neuron projection extension; IMP:RGD.
DR   GO; GO:0048812; P:neuron projection morphogenesis; ISO:RGD.
DR   GO; GO:0021772; P:olfactory bulb development; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IMP:RGD.
DR   GO; GO:0003184; P:pulmonary valve morphogenesis; ISO:RGD.
DR   GO; GO:0051414; P:response to cortisol; ISO:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; ISO:RGD.
DR   GO; GO:0035385; P:Roundabout signaling pathway; ISO:RGD.
DR   GO; GO:0021510; P:spinal cord development; IEP:RGD.
DR   GO; GO:0060074; P:synapse maturation; IDA:SynGO.
DR   GO; GO:0022029; P:telencephalon cell migration; ISO:RGD.
DR   GO; GO:0001657; P:ureteric bud development; ISO:RGD.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISO:RGD.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 5.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR002272; FSH_rcpt.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR050467; LRFN.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR000372; LRRNT.
DR   PANTHER; PTHR45842:SF12; KEKKON 5, ISOFORM A; 1.
DR   PANTHER; PTHR45842; SYNAPTIC ADHESION-LIKE MOLECULE SALM; 1.
DR   Pfam; PF13855; LRR_8; 6.
DR   Pfam; PF01463; LRRCT; 3.
DR   Pfam; PF01462; LRRNT; 4.
DR   PRINTS; PR01143; FSHRECEPTOR.
DR   PRINTS; PR00019; LEURICHRPT.
DR   SMART; SM00369; LRR_TYP; 14.
DR   SMART; SM00082; LRRCT; 3.
DR   SMART; SM00013; LRRNT; 4.
DR   SUPFAM; SSF52058; L domain-like; 3.
DR   PROSITE; PS51450; LRR; 16.
PE   1: Evidence at protein level;
KW   Chemotaxis; Developmental protein; Differentiation; Disulfide bond;
KW   Glycoprotein; Heparin-binding; Leucine-rich repeat; Neurogenesis;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..766
FT                   /note="Slit homolog 2 protein"
FT                   /id="PRO_0000007731"
FT   DOMAIN          31..55
FT                   /note="LRRNT"
FT   REPEAT          56..77
FT                   /note="LRR 1"
FT   REPEAT          80..101
FT                   /note="LRR 2"
FT   REPEAT          104..125
FT                   /note="LRR 3"
FT   REPEAT          128..149
FT                   /note="LRR 4"
FT   REPEAT          152..173
FT                   /note="LRR 5"
FT   REPEAT          176..197
FT                   /note="LRR 6"
FT   DOMAIN          209..259
FT                   /note="LRRCT 1"
FT   DOMAIN          268..304
FT                   /note="LRRNT 2"
FT   REPEAT          305..326
FT                   /note="LRR 7"
FT   REPEAT          329..350
FT                   /note="LRR 8"
FT   REPEAT          353..374
FT                   /note="LRR 9"
FT   REPEAT          377..398
FT                   /note="LRR 10"
FT   REPEAT          401..422
FT                   /note="LRR 11"
FT   DOMAIN          434..484
FT                   /note="LRRCT 2"
FT   DOMAIN          493..529
FT                   /note="LRRNT 3"
FT   REPEAT          530..551
FT                   /note="LRR 12"
FT   REPEAT          555..576
FT                   /note="LRR 13"
FT   REPEAT          579..600
FT                   /note="LRR 14"
FT   REPEAT          603..624
FT                   /note="LRR 15"
FT   REPEAT          627..648
FT                   /note="LRR 16"
FT   DOMAIN          660..710
FT                   /note="LRRCT 3"
FT   DOMAIN          714..750
FT                   /note="LRRNT 4"
FT   CARBOHYD        66
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        186
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        560
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        619
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        281..290
FT                   /evidence="ECO:0000250"
FT   DISULFID        438..461
FT                   /evidence="ECO:0000250"
FT   DISULFID        440..482
FT                   /evidence="ECO:0000250"
FT   DISULFID        502..508
FT                   /evidence="ECO:0000250"
FT   DISULFID        506..515
FT                   /evidence="ECO:0000250"
FT   DISULFID        664..687
FT                   /evidence="ECO:0000250"
FT   DISULFID        666..708
FT                   /evidence="ECO:0000250"
FT   DISULFID        723..729
FT                   /evidence="ECO:0000250"
FT   DISULFID        727..736
FT                   /evidence="ECO:0000250"
FT   NON_TER         766
SQ   SEQUENCE   766 AA;  86049 MW;  A380ACCE0A810FE1 CRC64;
     MSGIGWQTLS LSLALVLSIL NKVAPHACPA QCSCSGSTVD CHGLALRIVP RNIPRNTERL
     DLNGNNITRI TKTDFAGLRH LRILQLMENK ISTIERGAFH DLKELERLRL NRNNLQLFPE
     LLFLGTAKLY RLDLSENQIQ AIPRKAFRGA VDIKNLQLDY NQISCIEDGA FRALRDLEVL
     TLNNNNITRL SVASFNHMPK LRTFRLHSNN LYCDCHLAWL SDWLRQRPRV GLYTQCMGPS
     HLRGHNVAEV QKREFVCSDE EEGHQSFMAP SCSVLHCPIA CTCSNNIVDC RGKGLTEIPT
     NLPETITEIR LEQNSIRVIP PGAFSPYKKL RRLDLSNNQI SELAPDAFQG LRSLNSLVLY
     GNKITELPKS LFEGLFSLQL LLLNANKINC LRVDAFQDLH NLNLLSLYDN KLQTVAKGTF
     SALRAIQTMH LAQNPFICDC HLKWLADYLH TNPIETSGAR CTSPRRLANK RIGQIKSKKF
     RCSGTEDYRS KLSGDCFADL ACPEKCRCEG TTVDCSNQKL NKIPDHIPQY TAELRLNNNE
     FTVLEATGIF KKLPQLRKIN LSNNKITDIE EGAFEGASGV NEILLTSNRL ENVQHKMFKG
     LESLKTLMLR SNRISCVGND SFTGLGSVRL LSLYDNQITT VAPGAFGTLH SLSTLNLLAN
     PFNCNCHLAW LGEWLRRKRI VTGNPRCQKP YFLKEIPIQD VAIQDFTCDD GNDDNSCSPL
     SRCPSECTCL DTVVRCSNKG LKVLPKGIPR DVTELYLDGN QFTLVP
//
